Evidence map›Paper›PMID 29218044›Full record

ArticleFrontiers in immunology2017

Editorial: Ying and Yang Members of the Tumor Necrosis Factor Superfamily: Friends or Foes in Immune-Mediated Diseases and Cancer.

Adebola Giwa, Rizwan Ahmed, Thomas Donner, Hideo Yagita, Abdel Rahim A Hamad

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. IL-17 and limits of success.Cellular immunology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Adebola GiwaDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Rizwan AhmedDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Thomas DonnerDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Hideo YagitaDepartment of Immunology, Juntendo University School of Medicine, Tokyo, Japan.
Abdel Rahim A HamadDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

Funding

Institutional Training for PediatriciansT32HD044355 · NICHD · JOHNS HOPKINS UNIVERSITY · PI BRADY, TAMMY MCLOUGHLIN · 2003 to 2023
$4.1M
Mechanisms of Fas Ligand Control of Insulitis in Autoimmune DiabetesR01AI099027 · NIAID · JOHNS HOPKINS UNIVERSITY · PI HAMAD, ABDEL RAHIM · 2013 to 2017
$2.0M
NIAID NIH HHS R01 AI099027NICHD NIH HHS T32 HD044355
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CD95LFasLFas pathwaytumor necrosis factortype 1 diabetes

Identifiers

PMID29218044
PMCPMC5703765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.